The theory described in the peptide literature is that a GHRH analog (signal one) and a ghrelin-receptor agonist (signal two) act in a complementary, even synergistic, way producing a larger GH pulse together than either pathway alone, because the pituitary carries co-receptors for both inputs
As it does not directly suppress pigment production, Tretinoin suits milder, more superficial types of hyperpigmentation
As the GLP-1 revolution sweeps through medicine and pop culturecelebrated for melting away pounds and reshaping both the lives and self-esteem of users a new side effect is emerging in both doctor's offices and online forums: hair loss
In clinical studies in adult patients, there was a higher incidence of injection site pain in LANTUS-treated patients (2.7%) compared to NPH insulin-treated patients (0.7%)
Ovulation induction using sequential letrozole/gonadotrophin in infertile women with PCOS: a randomized controlled trial
On April 30, 2026, the FDA announced a formal proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List - the regulatory mechanism that governs which bulk substances large-scale 503B outsourcing facilities may use in compounding
